Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Scope of the Report:
This report focuses on the Octreotide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The production of Octreotide mainly focuses on Europe, China and India. The Europe occupies the largest share and it about reach 66.36% in 2015. Novartis exports to other countries mainly in the form of finished drug.
The Octreotide product increased fast in the past five years, the production growth in the past two years. There have been new manufacturers to enter the field year by year. But for now , it is difficult to obtain certification.
It will expect that the production and the capacity will increase fast in the future, But with octreotide acetate in China continues to mature in manufacturing technology, in the future, trade of octreotide API will gradually decrease, more and more Octreotide will sold as finished medicine.
The worldwide market for Octreotide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Treating Severe Diarrhea
There are 15 Chapters to deeply display the global Octreotide market.
Chapter 1, to describe Octreotide Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Octreotide, with sales, revenue, and price of Octreotide, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Octreotide, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Octreotide market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Octreotide sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source